IGF1R and cancer: IGF-1R overexpression is associated with an enhanced growth rate of cancer cells [6,8], and studies have shown that patients with advanced clinical stages of PDAC (stages II and III) have higher levels of IGF-1R and low IGFBP3, correlating with poor prognosis [9].